Surprise Bonus from Hormone Therapy in Menopause medpagetoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medpagetoday.com Daily Mail and Mail on Sunday newspapers.
Sean Locke/Stocksy
New research shows that many middle-aged women may be living with undiagnosed hypertension because symptoms of the condition including chest pain, exhaustion, headaches, heart palpitations, and sleep disturbances are mistakenly attributed to menopause.
Missed hypertension cases are part of a broader problem of overlooked cardiovascular disease among middle-aged women, according to a paper by a group of cardiologists, gynecologists, and endocrinologists published in January 2021 in the
European Heart Journal. Too often, these women have undiagnosed hypertension and other risk factors for cardiovascular disease because their doctors focus on signs common in men that aren’t as typical for women, the paper argues.
A study of 2,000 UK adults surveyed by Asian food brand Itsu found 49 per cent said they had no clue what a nutritious meal include, with two-thirds of people baffled by protein and fibre.
email article
The FDA approved fosdenopterin (Nulibry) the first specific treatment for the rare metabolic disorder molybdenum cofactor deficiency type A.
Hospitalized COVID-19 patients with low free T3 levels saw significantly higher rates of mortality, mechanical ventilation, and ICU admission. (
Endocrine Practice)
Almost a quarter of patients with kidney stone disease also had osteoporosis or a fracture, according to a study of over 500,000 people. (
Journal of Bone and Mineral Research)
In related news, women with primary ovarian insufficiency who experience early menopause have a higher risk for osteoporosis. This study . underscores the importance of the use of hormone therapy at least until the natural age of menopause in order to reduce the significant morbidity and mortality associated with osteoporotic fractures, commented Stephanie Faubion, MD, North American Menopause Society medical director. (
email article
Developing type 1 diabetes (T1D) in childhood was significantly associated with a shorter opportunity for childbearing, a new study showed.
Women diagnosed with T1D in childhood had an average 2.5 fewer reproductive years compared with their nondiabetic counterparts (95% CI -3.6 to -1.5,
P 0.0001), reported Tina Costacou, PhD, of the University of Pittsburgh, and colleagues.
Shortening of the reproductive window occurred on both sides, the researchers wrote in
Menopause, the journal of the North American Menopause Society (NAMS).
Specifically, women with T1D were an average 0.5 years older at the time of menarche and tended to be younger at the time of natural menopause onset, by 2 years on average. This was following adjustment for age, race, BMI, smoking status, hypertension, HDL cholesterol levels, history of oral contraceptives, and number of pregnancies.